ArticleIntestinal research2026

Post-marketing surveillance of tofacitinib in patients with ulcerative colitis in Japan: a post hoc analysis of safety and effectiveness in older (≥65 years) and younger (<65 years) patients.

Katsuyoshi Matsuoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.